Oxcarbazepine
Product Images NDC 63629-2075

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 63629-2075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636292075)

This is a prescription medicine called Oxcarbazepine Tablets, USP which comes in the strength of 300mg. The medicine should be kept safely away from children and stored at a temperature range of 20 degrees Celsius to 25 degrees Celsius. It should be dispensed in a tightly closed light-resistant container that comes with a child-resistant cap. The NDC (National Drug Code) for this medication is 63629-2075-1.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Figure 1 (Oxcarbazepine 02)

This text appears to be a graph displaying the exit rate over time on a trial, specifically examining the results from Day 2 to Day 11. The log-rank test was used with a p-value of 0.0001. The graph includes a reference to a placebo.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

The text presents the results of a study on the seizure rate using oxcarbazepine and placebo treatments. A log-rank test was used to analyze the data, and the obtained p-value is 0.046, suggesting that there is a significant difference between the treatment groups. The graph shows the number of days between the first dose and the first seizure for both treatments, where the Oxcarbazepine group had fewer seizures overall.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

This appears to be a statistical output of a log-rank test comparing two groups, a HIGH treatment group and a LOW treatment group, based on time to exit in days. The p-value is 0.0001, indicating a statistically significant difference between the two groups. The other characters seem to be errors and are not readable.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

This appears to be the result of a survival analysis, showing the exit rate, log-rank test p-value, and time to exit in days for a treatment group labeled "HIGH" and another labeled "LOW". Not much other information is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.